OBJECTIVE: Cigarette smoking is highly prevalent among people with bipolar disorder or schizophrenia. Few studies have examined whether smoking history is associated with adaptive functioning among individuals diagnosed with these serious mental illnesses. METHOD: In a large relatively homogenous cohort of patients with either bipolar disorder (n=363) or schizophrenia (n=400), we investigated the association between cigarette smoking status, intensity, and cumulative exposure and performance on a comprehensive battery of neurocognitive, functional capacity, and informant-rated functional measures. The associations were adjusted for variation in sociodemographic indicators, psychopathologic symptoms, and substance use. RESULTS: There was an average of 12 pack years of smoking across the sample. People with schizophrenia reported double the rate of current smoking compared to patients with bipolar disorder. Adjusting for demographic covariates, current smokers had worse composite cognitive functioning and poorer functional outcome than past or never smokers. There were no significant differences between never and past smokers, and these effects were evident in both bipolar disorder and schizophrenia. CONCLUSION: Current smokers with either schizophrenia or bipolar disorder evidence worse cognitive and adaptive functioning functional outcome, even when demographic covariates are considered.
OBJECTIVE: Cigarette smoking is highly prevalent among people with bipolar disorder or schizophrenia. Few studies have examined whether smoking history is associated with adaptive functioning among individuals diagnosed with these serious mental illnesses. METHOD: In a large relatively homogenous cohort of patients with either bipolar disorder (n=363) or schizophrenia (n=400), we investigated the association between cigarette smoking status, intensity, and cumulative exposure and performance on a comprehensive battery of neurocognitive, functional capacity, and informant-rated functional measures. The associations were adjusted for variation in sociodemographic indicators, psychopathologic symptoms, and substance use. RESULTS: There was an average of 12 pack years of smoking across the sample. People with schizophrenia reported double the rate of current smoking compared to patients with bipolar disorder. Adjusting for demographic covariates, current smokers had worse composite cognitive functioning and poorer functional outcome than past or never smokers. There were no significant differences between never and past smokers, and these effects were evident in both bipolar disorder and schizophrenia. CONCLUSION: Current smokers with either schizophrenia or bipolar disorder evidence worse cognitive and adaptive functioning functional outcome, even when demographic covariates are considered.
Authors: X Y Zhang; D C Chen; M H Xiu; C N Haile; S C He; X Luo; L Zuo; R Rosenheck; T A Kosten; T R Kosten Journal: Psychol Med Date: 2012-11-13 Impact factor: 7.723
Authors: Philip D Harvey; Robert K Heaton; William T Carpenter; Michael F Green; James M Gold; Michael Schoenbaum Journal: Schizophr Res Date: 2012-04-13 Impact factor: 4.939
Authors: Faith Dickerson; Catherine R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Jennifer Schroeder; Robert H Yolken Journal: Psychiatr Serv Date: 2013-01 Impact factor: 3.084
Authors: Kristen M Mackowick; Mera S Barr; Victoria C Wing; Rachel A Rabin; Clairelaine Ouellet-Plamondon; Tony P George Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2013-07-19 Impact factor: 5.067
Authors: Britta Hahn; Alexander N Harvey; Marta Concheiro-Guisan; Marilyn A Huestis; Henry H Holcomb; James M Gold Journal: Biol Psychiatry Date: 2013-05-06 Impact factor: 13.382
Authors: Jamie Joseph; William S Kremen; Carol E Franz; Stephen J Glatt; Joyce van de Leemput; Sharon D Chandler; Ming T Tsuang; Elizabeth W Twamley Journal: Schizophr Res Date: 2017-01-28 Impact factor: 4.939
Authors: Tyler B Grove; Kyle J Burghardt; A Zarina Kraal; Ryan J Dougherty; Stephan F Taylor; Vicki L Ellingrod Journal: Mol Neuropsychiatry Date: 2016-08-13
Authors: Camila N C Lima; Robert Suchting; Giselli Scaini; Valeria A Cuellar; Alexandra Del Favero-Campbell; Consuelo Walss-Bass; Jair C Soares; Joao Quevedo; Gabriel R Fries Journal: Eur Neuropsychopharmacol Date: 2022-07-08 Impact factor: 5.415
Authors: Suzanne H Gage; Hannah J Jones; Amy E Taylor; Stephen Burgess; Stanley Zammit; Marcus R Munafò Journal: Sci Rep Date: 2017-01-19 Impact factor: 4.379